+5.9%
HWM vs MRNA
+697.5%
-691.6%
-36.5%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | MRNA | Excess | Alpha |
|---|---|---|---|---|
| 1D | -4.1% | -2.2% | -2.0% | -4.1% |
| 7D | -5.3% | -12.7% | +7.4% | -5.3% |
| 30D | +0.6% | -20.7% | +21.2% | +0.6% |
| 3M | -23.5% | +46.3% | -69.8% | -23.3% |
| 6M | -19.8% | +305.2% | -325.1% | -21.1% |
| YTD | +2.2% | +561.2% | -559.0% | -2.8% |
| 1Y | +5.9% | +772.1% | -766.2% | -2.7% |
| All | +5.9% | +697.5% | -691.6% | -2.7% |
Cumulative growth
Daily Returns
Daily percentage return beside MRNA.
Daily Out/Under-Performance
Portfolio return minus MRNA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling